7799 — Heron Neutron Medical Cashflow Statement
0.000.00%
- TWD60.09bn
- TWD48.76bn
- 17
- 11
- 54
- 12
Annual cashflow statement for Heron Neutron Medical, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -86.2 | -126 | -260 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | -1.14 | -0.054 | 24.1 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 11.3 | 56.5 | -44.5 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -62 | -54.6 | -260 |
| Capital Expenditures | -114 | -56.2 | -49 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0.326 | 0 | -100 |
| Sale of Fixed Assets | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -114 | -56.2 | -149 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 178 | 336 | 900 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 2.77 | 225 | 491 |